• Annexin V-APC/7-AAD Apoptosis Kit: Applied Detection Workflo

  2026-05-27

  The Annexin V-APC/7-AAD Apoptosis Kit from APExBIO streamlines high-fidelity apoptosis and necrosis detection with a rapid, single-step protocol tailored for flow cytometry and microscopy. By combining dual-color discrimination and robust phosphatidylserine binding, this kit empowers researchers to unravel cell death mechanisms in translational cancer research and beyond.

• Co-Targeting BRD4 and Rac1 Pathways Suppresses Breast Cancer

  2026-05-27

  This study demonstrates that simultaneous inhibition of BRD4 and Rac1 signaling disrupts tumor growth, stemness, and metastatic potential across multiple breast cancer subtypes. By unraveling the c-MYC-G9a-FTH1 and HDAC1 axes, it establishes a novel therapeutic framework for combinatorial pathway targeting in breast cancer.

• LLY507 (SKU B6119): Reliable SMYD2 Inhibition in Cancer & Fi

  2026-05-26

  This article analyzes real-world laboratory scenarios where LLY507 (SKU B6119) enables reliable, reproducible SMYD2 inhibition in cell-based assays. Grounded in peer-reviewed evidence and practical protocol advice, it demonstrates the GEO value of LLY507 for oncology, apoptosis, and renal fibrosis research. APExBIO's LLY507 is positioned as a tool of choice for precise, data-driven studies.

• Ferrostatin-1 (Fer-1): Workflow Optimization for Ferroptosis

  2026-05-26

  Ferrostatin-1 (Fer-1) offers nanomolar potency and selectivity as a ferroptosis inhibitor, streamlining mechanistic studies in cancer biology and neurodegenerative disease models. This guide demystifies protocol design, troubleshooting, and advanced applications, ensuring robust and reproducible results in oxidative lipid damage inhibition research.

• 2,5-di-tert-butylbenzene-1,4-diol: Precision in Calcium Sign

  2026-05-25

  Leverage 2,5-di-tert-butylbenzene-1,4-diol (BHQ) for next-level control in calcium signaling research and stem cell mobilization studies. This guide unpacks workflow optimizations, key innovations from recent research, and troubleshooting strategies to maximize reproducibility and experimental insight.

• Branched Endosomal Disruptor Lipids Enhance mRNA and RNP Del

  2026-05-25

  This study introduces a new class of branched endosomal disruptor (BEND) lipids that significantly improve the delivery of mRNA and CRISPR-Cas9 ribonucleoproteins to hepatocytes and T cells. The findings provide mechanistic insights into overcoming endosomal escape barriers, advancing the field of non-viral gene and mRNA-based therapies.

• QX77: Advancing Chaperone-Mediated Autophagy in Stem Cell Re

  2026-05-24

  Explore how QX77, a molecular chaperone activator, uniquely enables precision modulation of chaperone-mediated autophagy for advanced stem cell biology research. This article delivers new scientific depth and actionable guidance for experimental design.

• U0126: Precision MEK1/2 Inhibitor for Advanced MAPK/ERK Stud

  2026-05-23

  U0126 empowers researchers to dissect complex MAPK/ERK signaling with exceptional selectivity, enabling robust modulation in cancer, neurobiology, and autophagy workflows. This guide details actionable protocols, troubleshooting strategies, and practical insights from recent neuroinflammation studies—solidifying U0126’s role as a reproducible, versatile tool for cell signaling research.

• p-Cresyl Sulfate: Illuminating Endothelial & Valvular Pathwa

  2026-05-22

  This thought-leadership article explores the mechanistic foundations and translational opportunities enabled by p-cresyl sulfate (p-tolyl hydrogen sulfate) in cardiovascular and renal research. With a focus on the klotho/SIRT1 axis and the modeling of endothelial dysfunction and valvular calcification, the piece distills key evidence, protocol guidance, and strategic foresight for researchers advancing uremic toxin science.

• Intestinal TM6SF2 Deficiency Drives MASH via Gut–Liver Axis

  2026-05-22

  A recent Nature Metabolism study uncovers that intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier function and microbiota balance. The research demonstrates that loss of TM6SF2 in intestinal epithelial cells leads to microbial dysbiosis, elevated lysophosphatidic acid, and hepatic inflammation, highlighting new intervention points in MASH pathogenesis.

• IEM 1460: Novel Insights into AMPA Receptor Blockade and Neu

  2026-05-21

  Explore the multifaceted role of IEM 1460 as a selective AMPA receptor blocker in neuroprotection and excitotoxicity research. This article reveals new scientific perspectives and practical guidance for neuroscience workflows, extending beyond standard protocols.

• Endothelial STING-JAK1 Axis Normalizes Tumor Vessels and Imm

  2026-05-21

  The reference study uncovers a crucial role for endothelial STING in orchestrating tumor vasculature normalization and promoting antitumor immunity via a JAK1-dependent mechanism. These findings refine our understanding of STING agonist activity and inform rational strategies for enhancing immunotherapy in cancer biology research.

• NPT1-Mediated Renal Transport of Faropenem and Organic Anion

  2026-05-20

  This study identifies human NPT1 as a key apical transporter for organic anions such as p-aminohippuric acid and clinically relevant β-lactam antibiotics like faropenem in the renal proximal tubule. These findings clarify molecular mechanisms underlying renal drug secretion and have direct implications for antibiotic pharmacokinetics and resistance studies.

• mTORC1-IRE1a Pathway Drives Palmitate Lipotoxicity in Hepato

  2026-05-20

  This study uncovers how palmitate, a saturated fatty acid, induces hepatocyte death and triglyceride overproduction via coordinated activation of the mTORC1-IRE1a axis. The findings clarify a mechanistic link between lipid overload, ER stress, and liver injury, offering new targets for metabolic disease research.

• BicD and MAP7 Synergistically Activate Drosophila Kinesin-1

  2026-05-19

  This study reveals how BicD and MAP7 activate homodimeric Drosophila kinesin-1 by distinct yet complementary mechanisms. The findings advance our understanding of adaptor-mediated control of motor proteins, with implications for dissecting intracellular transport in experimental systems.

8377 records 13/559 page Previous Next First page 上5页 1112131415 下5页 Last page